What are the treatments for hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hypotension

The first-line treatment for hypotension depends on its cause, with fluid resuscitation being the primary intervention for most forms, followed by vasopressors if fluid resuscitation fails to restore adequate blood pressure. 1

Initial Assessment and Management

  • Test for orthostatic hypotension before starting treatment by measuring blood pressure after 5 minutes of sitting/lying and then 1 and/or 3 minutes after standing 2
  • For mild hypotension, administer small boluses (5-10 mL/kg) of normal saline or balanced crystalloids 3
  • Consider patient positioning - elevate legs to improve venous return 3
  • If medication-induced, reduce or temporarily discontinue the causative medications 3

Fluid Resuscitation

  • Crystalloids are the fluid of choice for initial resuscitation of hypotension 3
  • For significant hypotension, administer an initial fluid challenge of 30 mL/kg 3
  • Continue fluid administration as long as there is hemodynamic improvement based on dynamic or static variables 3
  • Consider albumin in addition to crystalloids when substantial amounts of crystalloids are required 3

Vasopressor Therapy

  • Initiate vasopressor therapy if hypotension persists despite adequate fluid resuscitation 1, 3
  • Target a mean arterial pressure (MAP) of 65 mmHg 1, 3
  • Norepinephrine is the first-choice vasopressor for hypotension unresponsive to fluids 1, 3
  • For refractory hypotension, consider adding vasopressin (up to 0.03 U/min) or epinephrine to norepinephrine 1, 3
  • Dopamine should only be considered in highly selected patients with low risk of tachyarrhythmias or with relative bradycardia 1, 3

Management of Orthostatic Hypotension

Non-Pharmacological Approaches

  • Increase fluid intake to 2-3 liters daily and salt consumption to 6-9g daily, if not contraindicated 2
  • Implement physical counter-maneuvers, such as leg crossing, muscle tensing, squatting, and stooping 2, 4
  • Use compression garments, including thigh-high and abdominal compression 2
  • Acute water ingestion of ≥480 mL can provide temporary relief, with peak effect occurring 30 minutes after consumption 2, 5, 6
  • Recommend smaller, more frequent meals to reduce post-prandial hypotension 2
  • Encourage physical activity and exercise to avoid deconditioning 2

Pharmacological Treatment for Orthostatic Hypotension

  • Consider pharmacological treatment when non-pharmacological measures fail to adequately control symptoms 2
  • First-line medications include:
    • Midodrine (alpha-1 agonist): Initial dose 2.5-5mg three times daily, can increase standing systolic BP by 15-30 mmHg for 2-3 hours 2, 7
    • Fludrocortisone (mineralocorticoid): Initial dose 0.05-0.1mg daily, works by increasing plasma volume 2
    • Droxidopa: Particularly effective for neurogenic orthostatic hypotension 2

Special Considerations

Cardiogenic Shock

  • In cardiogenic shock, individualize MAP goals to balance hypoperfusion risk against potential negative impact on cardiac output 1
  • For acute heart failure, inotropes (dobutamine, dopamine, phosphodiesterase III inhibitors) are recommended as first-line agents 1
  • In persistently hypotensive cardiogenic shock with tachycardia, norepinephrine is advised 1
  • In patients with bradycardia, dopamine may be considered 1

Distributive Shock

  • In distributive shock (e.g., sepsis), norepinephrine is recommended as the initial vasoactive drug after appropriate fluid resuscitation 1
  • If hypotension persists, vasopressin (up to 0.03 UI/min) should be considered 1
  • For myocardial depression in septic shock, consider adding dobutamine to norepinephrine or using epinephrine as a single agent 1

Medication-Induced Hypotension

  • For patients on beta-blockers with hypotension, consider glucagon (5-10 mg infused over several minutes followed by 1-5 mg/hour IV infusion) 3
  • For patients with both hypertension and orthostatic hypotension, consider long-acting dihydropyridine calcium channel blockers or RAS inhibitors 2

Monitoring and Weaning

  • Administration of vasoactive agents should always be targeted to effect and not based on a fixed dose 1
  • Monitor blood pressure using intra-arterial monitoring when using vasopressors 1
  • Complement MAP targets with other markers of perfusion, such as lactate, mixed or central venous oxygen saturations, urine output, skin perfusion, and mental status 1

Pitfalls and Caveats

  • Avoid delaying vasopressor use in cases of significant hypotension unresponsive to fluids 3
  • Avoid hydroxyethyl starches due to potential adverse effects 3
  • When using midodrine, avoid taking the last dose after 6 PM to prevent supine hypertension during sleep 2
  • Regular monitoring for adverse effects is essential, especially supine hypertension with pressor agents and electrolyte abnormalities with fludrocortisone 2
  • For orthostatic hypotension, the therapeutic goal should be minimizing postural symptoms rather than restoring normotension 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Orthostatic Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Hypotension Secondary to Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation and management of orthostatic hypotension.

American family physician, 2011

Research

Water drinking as a treatment for orthostatic syndromes.

The American journal of medicine, 2002

Research

Acute effect of water on blood pressure. What do we know?

Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.